Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer.

Abstract

Sensitivity of the FISH assay is superior to that of cytology and at least equivalent to the BTA Stat test in detecting recurrent transitional cell carcinoma. Its specificity approaches that of cytology. Further testing of its clinical use is warranted.